Wall Street Journal. Europe 1999 Michael Reid - Abstracts
| Wall Street Journal. Europe 1999 Michael Reid | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Albemarle offers to buy Albright for $656 million.(Abstract) | Business, international | Michael Reid | |||
| British Biotech sees shares jump on drug talks. | Business, international | Michael Reid | |||
| Clariant net surpasses expectations.(Abstract) | Business, international | Michael Reid | |||
| ICI reports 17% decline in pretax profit.(Abstract) | Business, international | Michael Reid | |||
| Shield Diagnostics shares are mired despite claim of progress with Axis.(Abstract) | Business, international | Michael Reid | |||
| SmithKline hopes new diabetes drug will fuel growth.(Abstract) | Business, international | Michael Reid | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.